News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
324,205 Results
Type
Article (19369)
Company Profile (124)
Press Release (304712)
Section
Business (104973)
Career Advice (857)
Deals (18475)
Drug Delivery (83)
Drug Development (50506)
Employer Resources (79)
FDA (7583)
Job Trends (7700)
News (184997)
Policy (17263)
Tag
Academia (725)
Africa (406)
Alliances (27622)
Alzheimer's disease (523)
Antibody-drug conjugate (ADC) (39)
Approvals (7543)
Arizona (45)
Artificial intelligence (53)
Asia (24249)
Australia (3110)
Bankruptcy (172)
Best Places to Work (5358)
Biosimilars (57)
Biotechnology (60)
C2C Services and Suppliers (13089)
California (870)
Canada (549)
Cancer (272)
Cardiovascular disease (35)
Career advice (694)
Cell therapy (40)
China (86)
Clinical research (41108)
Collaboration (83)
Colorado (33)
Compensation (32)
COVID-19 (1052)
Cystic fibrosis (42)
Data (184)
Diabetes (53)
Diagnostics (1667)
Drug pricing (76)
Earnings (37690)
Employer resources (71)
Europe (49902)
Events (46838)
Executive appointments (102)
FDA (7690)
Florida (111)
Funding (60)
Gene therapy (58)
GLP-1 (428)
Government (1772)
Healthcare (5833)
Hotbed/Location (218881)
Illinois (94)
Indiana (79)
Infectious disease (1074)
Inflammatory bowel disease (60)
Interviews (113)
IPO (7247)
Job creations (2424)
Job search strategy (642)
Kansas (54)
Layoffs (241)
Legal (4059)
Lung cancer (68)
Manufacturing (67)
Maryland (139)
Massachusetts (748)
Medical device (1929)
Medtech (1932)
Mergers & acquisitions (11155)
Metabolic disorders (217)
Minnesota (61)
Neuroscience (620)
New Jersey (354)
New York (267)
NextGen Class of 2024 (2340)
Non-profit (898)
North Carolina (290)
Northern California (394)
Obesity (140)
Ohio (47)
Opinion (166)
Patents (55)
Pennsylvania (242)
People (32636)
Pharmaceutical (63)
Phase I (12767)
Phase II (17412)
Phase III (14033)
Pipeline (76)
Podcasts (49)
Policy (56)
Postmarket research (1608)
Preclinical (4478)
Rare diseases (86)
Real estate (3159)
Regulatory (11927)
Research institute (814)
Resumes & cover letters (138)
South America (601)
Southern California (363)
Startups (2003)
Texas (105)
United States (3809)
Vaccines (176)
Washington State (100)
Weight loss (143)
Date
Today (54)
Last 7 days (327)
Last 30 days (1225)
Last 365 days (18576)
2024 (13120)
2023 (19635)
2022 (25870)
2021 (26641)
2020 (24873)
2019 (20058)
2018 (15587)
2017 (17255)
2016 (16202)
2015 (18801)
2014 (14787)
2013 (12552)
2012 (13482)
2011 (13817)
2010 (12738)
324,205 Results for "amryt pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Former Amryt Pharma Leadership Team join Poolbeg
Poolbeg Pharma, a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announces the appointment of key former executives of Amryt Pharma plc to its leadership team.
November 9, 2023
·
6 min read
Deals
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici.
March 22, 2023
·
6 min read
FDA
Chiesi’s $1.25B Amryt Buy Pays Off with FDA Approval of Filsuvez
Chiesi Global Rare Diseases gained access to the Filsuvez topical gel in January 2023, when it bought Amryt Pharma. Tuesday’s approval comes nearly two years after an initial rejection by the regulator.
December 20, 2023
·
2 min read
·
Tristan Manalac
Deals
Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
Chiesi Farmaceutici S.p.A. announced the completion of the acquisition of Amryt Pharma Plc, a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing, and commercializing novel treatments for rare diseases.
April 12, 2023
·
3 min read
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
Deals
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
Chiesi Farmaceutici S.p.A. and Amryt Pharma Plc announced that the companies have entered into a definitive agreement under which Chiesi will acquire Amryt.
January 8, 2023
·
12 min read
Business
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
September 6, 2024
·
1 min read
·
Angela Gabriel
Mergers & acquisitions
Broken Deals: 4 Pharma Assets Returned to Biotech This Year
Not all licensing deals are successful. Here,
BioSpace
examines a few noteworthy assets that Big Pharma returned in the last 12 months.
August 27, 2024
·
5 min read
·
Mollie Barnes
Approvals
ARS Pharma Gets FDA Green Light for First Nasal Spray for Severe Allergic Reactions
ARS Pharma’s neffy on Friday became the first FDA-approved nasal spray to address severe allergic reactions, including those that might lead to life-threatening anaphylaxis.
August 12, 2024
·
2 min read
·
Tristan Manalac
Business
FSD Pharma provides Corporate Update
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.
June 28, 2024
·
10 min read
1 of 32,421
Next
